<VariationArchive RecordType="classified" VariationID="1804929" VariationName="NM_001127898.4(CLCN5):c.1452del (p.Glu484fs)" VariationType="Deletion" Accession="VCV001804929" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-07-29" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1861944" VariationID="1804929">
      <GeneList>
        <Gene Symbol="CLCN5" FullName="chloride voltage-gated channel 5" GeneID="1184" HGNC_ID="HGNC:2023" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="49922596" stop="50099230" display_start="49922596" display_stop="50099230" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="49687224" stop="49863891" display_start="49687224" display_stop="49863891" Strand="+" />
          </Location>
          <OMIM>300008</OMIM>
          <Haploinsufficiency last_evaluated="2012-10-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CLCN5">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-10-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CLCN5">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001127898.4(CLCN5):c.1452del (p.Glu484fs)</Name>
      <CanonicalSPDI>NC_000023.11:50086763:AA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="50086764" stop="50086764" display_start="50086764" display_stop="50086764" variantLength="1" positionVCF="50086763" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="49851421" stop="49851421" display_start="49851421" display_stop="49851421" variantLength="1" positionVCF="49851420" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>E414fs</ProteinChange>
      <ProteinChange>E434fs</ProteinChange>
      <ProteinChange>E484fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.49851422del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.49851422del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.50086765del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.50086765del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007159.3" sequenceAccession="NG_007159" sequenceVersion="3" change="g.169150del">
            <Expression>NG_007159.3:g.169150del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000084.5" sequenceAccession="NM_000084" sequenceVersion="5" change="c.1242del">
            <Expression>NM_000084.5:c.1242del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000075.1" sequenceAccession="NP_000075" sequenceVersion="1" change="p.Glu414fs">
            <Expression>NP_000075.1:p.Glu414fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127898.4" sequenceAccession="NM_001127898" sequenceVersion="4" change="c.1452del" MANESelect="true">
            <Expression>NM_001127898.4:c.1452del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121370.1" sequenceAccession="NP_001121370" sequenceVersion="1" change="p.Glu484fs">
            <Expression>NP_001121370.1:p.Glu484fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127899.4" sequenceAccession="NM_001127899" sequenceVersion="4" change="c.1452del">
            <Expression>NM_001127899.4:c.1452del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121371.1" sequenceAccession="NP_001121371" sequenceVersion="1" change="p.Glu484fs">
            <Expression>NP_001121371.1:p.Glu484fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282163.2" sequenceAccession="NM_001282163" sequenceVersion="2" change="c.1302del">
            <Expression>NM_001282163.2:c.1302del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269092.1" sequenceAccession="NP_001269092" sequenceVersion="1" change="p.Glu434fs">
            <Expression>NP_001269092.1:p.Glu434fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_073607.1" sequenceAccession="NR_073607" sequenceVersion="1" change="n.1533delA">
            <Expression>NR_073607.1:n.1533delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001127898.4(CLCN5):c.1452del (p.Glu484fs) AND Dent disease type 1" Accession="RCV002471347" Version="1">
        <ClassifiedConditionList TraitSetID="3210">
          <ClassifiedCondition DB="MedGen" ID="C1848336">Dent disease type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-05-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-05-06" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-24" MostRecentSubmission="2022-12-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12637640</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28580211</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3210" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="968" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NEPHROLITHIASIS, HYPERCALCIURIC, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="300009" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nephrolithiasis, hypercalciuria X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Urolithiasis, hypercalciuric X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nephrolithiasis 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Dent disease type 1</ElementValue>
                <XRef ID="MONDO:0010225" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nephrolithiasis, hypercalciuric</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NPHL2</ElementValue>
                <XRef Type="MIM" ID="300009" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dent disease, an X-linked disorder of proximal renal tubular dysfunction, is characterized by low molecular weight (LMW) proteinuria, hypercalciuria, and at least one additional finding including nephrocalcinosis, nephrolithiasis, hematuria, hypophosphatemia, chronic kidney disease (CKD), and evidence of X-linked inheritance. Males younger than age ten years may manifest only LMW proteinuria and/or hypercalciuria, which are usually asymptomatic. Thirty to 80% of affected males develop end-stage renal disease (ESRD) between ages 30 and 50 years; in some instances ESRD does not develop until the sixth decade of life or later. The disease may also be accompanied by rickets or osteomalacia, growth restriction, and short stature. Disease severity can vary within the same family. Males with Dent disease 2 (caused by pathogenic variants in OCRL) may also have mild intellectual disability, cataracts, and/or elevated muscle enzymes. Due to random X-chromosome inactivation, some female carriers may manifest hypercalciuria and, rarely, renal calculi and moderate LMW proteinuria. Females rarely develop CKD.</Attribute>
                <XRef ID="NBK99494" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22876375</ID>
                <ID Source="BookShelf">NBK99494</ID>
              </Citation>
              <XRef ID="1652" DB="Orphanet" />
              <XRef ID="93622" DB="Orphanet" />
              <XRef ID="C1848336" DB="MedGen" />
              <XRef ID="MONDO:0010225" DB="MONDO" />
              <XRef Type="MIM" ID="300009" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5412764" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_001127898_3_CLCN5_c_1452delA" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002767310" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12637640</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28580211</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Dent disease (MIM#300009). (I) 0115 - Variants in this gene are known to have variable expressivity. The phenotype can be variable within and between families (PMID: 28580211). (I) 0109 - This gene is associated with X-linked recessive disease. Dent disease (MIM#300009) is now the generally accepted name for a group of hereditary tubular disorders including X-linked recessive nephrolithiasis type I (MIM#310468), hypophosphataemic rickets (MIM#300554), and low molecular weight proteinuria with hypercalciuric nephrocalcinosis (MIM#308990) (PMID: 12637640). Dent disease (MIM#300009) mainly affects males, however female carriers may show a milder phenotype (PMID: 28580211). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0253 - This variant is hemizygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. Many other loss of function variants have previously been reported as pathogenic in individuals with Dent disease (MIM#300009) (ClinVar). (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CLCN5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_6401</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001127898.3:c.1452delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300009" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5412764" TraitType="Disease" MappingType="XRef" MappingValue="300009" MappingRef="OMIM">
        <MedGen CUI="C1848336" Name="Dent disease type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

